Epiminder Limited (ASX:EPI)
Australia · Delayed Price · Currency is AUD 0.2900
+0.0050 (1.75%)
At close: Sep 17, 2026
Epiminder Market Cap
Epiminder has a market cap or net worth of 62.83 million as of September 17, 2026.
Market Cap
62.83M
Enterprise Value
46.57M
Revenue
2.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
ChartMarket Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 62.83M, a decrease of -77.83%. That is a compound annual growth rate of -84.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 62.83M | -71.53% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 105.85M |
| Lumos Diagnostics Holdings | 94.48M |
| SomnoMed | 70.33M |
| Cyclopharm | 67.90M |
| Compumedics | 54.93M |
| Cleo Diagnostics | 45.93M |
| Nova Eye Medical | 38.46M |
| HeraMED | 38.24M |